GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dingdang Health Technology Group Ltd (HKSE:09886) » Definitions » Operating Income

Dingdang Health Technology Group (HKSE:09886) Operating Income : HK$-215 Mil (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Dingdang Health Technology Group Operating Income?

Dingdang Health Technology Group's Operating Income for the six months ended in Dec. 2024 was HK$-105 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-215 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Dingdang Health Technology Group's Operating Income for the six months ended in Dec. 2024 was HK$-105 Mil. Dingdang Health Technology Group's Revenue for the six months ended in Dec. 2024 was HK$2,564 Mil. Therefore, Dingdang Health Technology Group's Operating Margin % for the quarter that ended in Dec. 2024 was -4.09%.

Good Sign:

Dingdang Health Technology Group Ltd operating margin is expanding. Margin expansion is usually a good sign.

Dingdang Health Technology Group's 5-Year average Growth Rate for Operating Margin % was 13.80% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Dingdang Health Technology Group's annualized ROC % for the quarter that ended in Dec. 2024 was -23.36%. Dingdang Health Technology Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was -230.41%.


Dingdang Health Technology Group Operating Income Historical Data

The historical data trend for Dingdang Health Technology Group's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dingdang Health Technology Group Operating Income Chart

Dingdang Health Technology Group Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Operating Income
Get a 7-Day Free Trial -177.42 -800.53 -355.70 -294.03 -214.58

Dingdang Health Technology Group Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -116.00 -161.49 -132.54 -110.74 -104.75

Dingdang Health Technology Group Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-215 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dingdang Health Technology Group  (HKSE:09886) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Dingdang Health Technology Group's annualized ROC % for the quarter that ended in Dec. 2024 is calculated as:

ROC % (Q: Dec. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2024 ) + Invested Capital (Q: Dec. 2024 ))/ count )
=-209.5 * ( 1 - -1.3% )/( (998.02 + 819.201)/ 2 )
=-212.2235/908.6105
=-23.36 %

where

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3219.288 - 793.499 - ( 1427.769 - max(0, 985.573 - 2506.199+1427.769))
=998.02

Invested Capital(Q: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2810.834 - 691.258 - ( 1300.375 - max(0, 888.325 - 2350.601+1300.375))
=819.201

Note: The Operating Income data used here is two times the semi-annual (Dec. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Dingdang Health Technology Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Dec. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-601.986/( ( (237.301 + max(-0.45199999999988, 0)) + (219.828 + max(65.407, 0)) )/ 2 )
=-601.986/( ( 237.301 + 285.235 )/ 2 )
=-601.986/261.268
=-230.41 %

where Working Capital is:

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(118.617 + 672.453 + 131.193) - (793.499 + 0 + 129.216)
=-0.45199999999988

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(126.247 + 609.903 + 158.936) - (691.258 + 0 + 138.421)
=65.407

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2024) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Dingdang Health Technology Group's Operating Margin % for the quarter that ended in Dec. 2024 is calculated as:

Operating Margin %=Operating Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-104.75/2563.677
=-4.09 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Dingdang Health Technology Group Operating Income Related Terms

Thank you for viewing the detailed overview of Dingdang Health Technology Group's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Dingdang Health Technology Group Business Description

Traded in Other Exchanges
N/A
Address
Dengshikou Street, Building 1, Yard 50, Dongcheng District, Beijing, CHN
Dingdang Health Technology Group Ltd is an investment holding company and its subsidiaries are principally engaged in the provision of pharmaceutical and healthcare business in the PRC. It is transforming and reshaping China's healthcare industry by pioneering on-demand pharmaceutical retail and medical consultation, with online-to-offline solutions.
Executives
Shen Zhen Zhao Yin Dian Xin Gu Quan Tou Zi Ji Jin Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Shen Zhen Zhao Yin Dian Xin Xin Qu Shi Gu Quan Tou Zi Ji Jin He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Guang Zhou Shi Zhao Xin Wu Ji Gu Quan Tou Zi He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Tian Jin Shan Hai Yi Hao Qi Ye Guan Li Zi Xun He Huo Qi Ye You Xian He Huo 2101 Beneficial owner
Zhao Yin Guo Ji Jin Rong Kong Gu Shen Zhen You Xian Gong Si 2201 Interest of corporation controlled by you
Yang Xiao
Yang Yibin
Yang Wenlong
Chuang Ji Tou Zi You Xian Gong Si
Zhi Sheng Qi Ye You Xian Gong Si
Jin Fa You Xian Gong Si
Jian Fa You Xian Gong Si
Zhi Ying Ji Tuan You Xian Gong Si
Jian Xing You Xian Gong Si
Xing Xin You Xian Gong Si

Dingdang Health Technology Group Headlines

No Headlines